drugset / Trial / NCT00827281

D-Cycloserine Enhancement of Exposure-Based CBT for Smoking Cessation (DCSSmoking)

NCT00827281 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

This study examines whether isolated doses of D-cycloserine enhance the efficacy of CBT for smoking cessation.

Timeline

Start
2008-08
Primary completion
2015-07-15
Completion
2015-07-15

Outcome

Outcome not reported

Stopped (Business): “Study was not funded and pilot work proved impractical.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Cycloserine Small molecule — —

Indications

No indication recorded.